Reannon Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.82 Cr
as on 16-11-2024
- Company Age 7 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 2.74%
(FY 2023)
About Reannon Pharma
The Corporate was formerly known as Reannon Pharmaceuticals India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhimrao Gole, Shobha Bhimrao, and Hrishikesh Gole serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PLC302728
- Company No.
302728
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Reannon Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhimrao Gole  | Director | 19-Mar-2019 | Current |
| Shobha Bhimrao | Director | 11-Dec-2017 | Current |
| Hrishikesh Gole | Director | 11-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Reannon Pharma.
Reannon Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Reannon Pharma?
In 2022, Reannon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Reannon Impex Private LimitedActive 3 years 11 monthsBhimrao Gole and Hrishikesh Gole are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reannon Pharma?
Unlock and access historical data on people associated with Reannon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reannon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reannon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
